Technical Analysis for QNRX - Quoin Pharmaceuticals, Ltd.

Grade Last Price % Change Price Change
F 0.59 -5.65% -0.04
QNRX closed down 5.65 percent on Friday, November 22, 2024, on 2 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
50 DMA Resistance Bearish -5.65%
Wide Bands Range Expansion -5.65%
Oversold Stochastic Weakness -5.65%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 15 hours ago
Down 5% about 15 hours ago
Down 3% about 18 hours ago
Fell Below Previous Day's Low about 18 hours ago
Down 2 % about 18 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Founded in 2018 as Quoin Pharmaceuticals Inc. by Michael Myers Ph.D. and Denise Carter, Quoin is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin’s innovative pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa and others.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Pharmaceutical Therapeutic Products Genodermatoses Epidermolysis Bullosa Netherton Syndrome Rare And Orphan Diseases

Is QNRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.18
52 Week Low 0.4772
Average Volume 2,801,668
200-Day Moving Average 0.87
50-Day Moving Average 0.63
20-Day Moving Average 0.69
10-Day Moving Average 0.62
Average True Range 0.08
RSI (14) 40.83
ADX 43.13
+DI 29.20
-DI 16.81
Chandelier Exit (Long, 3 ATRs) 0.72
Chandelier Exit (Short, 3 ATRs) 0.81
Upper Bollinger Bands 0.87
Lower Bollinger Band 0.51
Percent B (%b) 0.2
BandWidth 51.21
MACD Line -0.02
MACD Signal Line -0.01
MACD Histogram -0.0141
Fundamentals Value
Market Cap 577.52 Thousand
Num Shares 987 Thousand
EPS 1.38
Price-to-Earnings (P/E) Ratio 0.42
Price-to-Sales 0.00
Price-to-Book 0.45
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.62
Resistance 3 (R3) 0.63 0.62 0.62
Resistance 2 (R2) 0.62 0.61 0.62 0.62
Resistance 1 (R1) 0.60 0.60 0.60 0.60 0.61
Pivot Point 0.59 0.59 0.59 0.59 0.59
Support 1 (S1) 0.58 0.58 0.57 0.57 0.56
Support 2 (S2) 0.57 0.58 0.57 0.55
Support 3 (S3) 0.55 0.57 0.55
Support 4 (S4) 0.55